Clinicopathological data | n | miR-21 expression | p | PEG3 expression | p | ||
---|---|---|---|---|---|---|---|
Low expression group (n = 35) | High expression group (n = 36) | Low expression group (n = 36) | High expression group (n = 35) | ||||
Age (year) | Â | Â | Â | 0.188 | Â | Â | 0.736 |
< 50 | 44 | 19 | 25 |  | 23 | 21 |  |
≥ 50 | 27 | 16 | 11 |  | 13 | 14 |  |
Gender | Â | Â | Â | 0.559 | Â | Â | 0.288 |
Male | 39 | 18 | 21 | Â | 22 | 17 | Â |
Female | 32 | 17 | 15 | Â | 14 | 18 | Â |
Tumor location | Â | Â | Â | 0.196 | Â | Â | 0.168 |
Forehead | 22 | 13 | 9 | Â | 10 | 12 | Â |
Crown | 19 | 6 | 13 | Â | 12 | 7 | Â |
Pulvinar | 16 | 7 | 9 | Â | 10 | 6 | Â |
Temple | 14 | 9 | 5 | Â | 4 | 10 | Â |
WHO classification | Â | Â | Â | 0.005 | Â | Â | 0.001 |
I + II | 41 | 26 | 15 |  | 14 | 27 |  |
III + IV | 30 | 9 | 21 |  | 22 | 8 |  |
KPS score | Â | Â | Â | 0.281 | Â | Â | 0.120 |
< 70 | 33 | 14 | 19 |  | 20 | 13 |  |
≥ 70 | 38 | 21 | 17 |  | 16 | 22 |  |
Tumor size (cm) | Â | Â | Â | 0.024 | Â | Â | 0.006 |
< 5 | 37 | 23 | 14 |  | 13 | 24 |  |
≥ 5 | 34 | 12 | 22 |  | 23 | 11 |  |